Novel triazolothiadiazines act as potent anticancer agents in liver cancer cells through Akt and ASK-1 proteins

Peri S Aytaç, Irem Durmaz, Douglas R Houston, Rengül Çetin-Atalay, Birsen Tozkoparan

Research output: Contribution to journalArticlepeer-review

Search results